The invention relates to a bispecific HER2-targeting agent comprisinga. a first polypeptide ligand that binds to HER2 extracellular domain 1,b. a second polypeptide ligand that binds to HER2 extracellular domain 4 andc. a linker covalently attaching said first polypeptide ligand to said second polypeptide ligand.